谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Phase II Trial of UGT1A1 Genotype-Guided FOLFIRI Plus Bevacizumab As First-Line Therapy for Advanced, Unresectable Colorectal Cancer.

Hanna K. Sanoff,Allison M. Deal,Jai Patel,Jonathan D. Sorah, Jacquelyne Gaddy,Bert O'Neil,Anita Turk,William Irvin,Jeremiah Boles,Michael S. Lee,Autumn McRee,Alexis C. Wardell,Karen E. Weck,Ethan Basch,William A. Wood,Federico Innocenti

The Oncologist（2024）

引用 0|浏览19
关键词
colorectal cancer,irinotecan,FOLFIRI,bevacizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要